A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show.

A study reveals why monkeys resist HBV infection, showing that specific amino acid differences in their NTCP receptor prevent ...

A groundbreaking study has identified a naturally occurring ligand derived from vitamin B6 that can activate immune cells to ...

Adoptive cell transfer with chimeric antigen receptor (CAR)-expressing T cells can induce remarkable complete responses in ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that abstracts related to lacutamab health-related quality of life and translational data from the ...

Dysregulated cell signaling underlies various diseases, emphasizing the importance of understanding these pathways for ...

Immunotherapies have shaped the cancer research space over the past decade, proving effective for the treatment of some ...

A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia, showing high response rates in ...

Roche will acquire Poseida Therapeutics, building on a partnership for CAR T-cell therapies in development for MS and other ...

The original pandemic virus before it was supplanted by SARS-CoV-2 is still influenza. Over the centuries, influenza pandemics have decimated human populations. One of the worst in history is the 1918 ...

A decade after the discovery of CALR, the results are the first for a possible therapy for CALR-mutated MPNs to reach the ...

A review discussing the therapeutic potentials of NK cell biology has been published in the journal Frontiers of Medicine.